PMC:7408073 / 103474-103687
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T21 | 45-49 | Body_part | denotes | sole | http://purl.org/sig/ont/fma/fma25000 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3574 | 10-15 | Gene | denotes | renin | Gene:5972 |
3591 | 194-206 | Disease | denotes | hypertension | MESH:D006973 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T563 | 194-206 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T25987 | 16-26 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T36125 | 28-37 | Chemical | denotes | aliskiren | http://purl.obolibrary.org/obo/CHEBI_601027 |
T21 | 76-81 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T506 | 0-213 | Sentence | denotes | Regarding renin inhibitors, aliskiren is the sole compound in this class of drugs that was approved by the US Food and Drug Administration in March 2007 and commercialized for the management of hypertension [186]. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T165 | 194-206 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |